MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.460
+0.020 (1.39%)
At close: Aug 21, 2026, 4:00 PM EDT
1.462
+0.002 (0.14%)
After-hours: Aug 21, 2026, 7:57 PM EDT
MetaVia Market Cap
MetaVia has a market cap or net worth of $9.62 million as of August 21, 2026. Its market cap has decreased by -35.90% in one year.
Market Cap
9.62M
Enterprise Value
-2.84M
1-Year Change
-35.90%
Ranking
Category
Stock Price
$1.46
ChartMarket Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $9.62M, a decrease of -99.99%. That is a compound annual growth rate of -75.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 9.62M | -48.11% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 10.78M |
| GT Biopharma | 10.41M |
| Vistagen Therapeutics | 10.01M |
| Skye Bioscience | 9.84M |
| Lunai Bioworks | 9.77M |
| OSR Health | 9.72M |
| FibroBiologics | 9.59M |
| AEON Biopharma | 9.58M |